NVDA
NVIDIA Corporation
NVDA has the edge over STM overall, supported by stronger valuation and stronger fundamentals.
STM
STMicroelectronics N.V.
STM's outlook is improving despite an expensive valuation.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
STM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
STM's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over STM in the historical PE scenario, which offers more potential upside but is not a forecast.
STM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $5.40 | -88% |
| Fair | 21x | $11.96 | -74% |
| Expensive | 40x | $22.34 | -52% |
| Current | 83x | $46.46 | — |
Historical ranges are pointers, not guarantees.
STM's PE is in its expensive range at 83x.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
STM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
STM has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over STM on earnings, with more consistent year-over-year improvement.
STM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.56 | -1.8% |
| Q2 2026 | $0.51 | -25% |
| Q1 2026 | $0.16 | -86% |
| Q4 2025 | $0.18 | -89% |
| Q3 2025 | $0.57 | -77% |
| Q2 2025 | $0.68 | -79% |
| Q1 2025 | $1.17 | -70% |
| Q4 2024 | $1.65 | -63% |
STM's earnings per share have fallen from their peak: $0.56 over the past year, against $4.89 in early 2023.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over STM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over STM on profitability, with a higher operating margin.
STM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.8B | +18% |
| Q2 2026 | $3.5B | +24% |
| Q1 2026 | $3.1B | +23% |
| Q4 2025 | $3.3B | +0.1% |
| Q3 2025 | $3.2B | -2.4% |
| Q2 2025 | $2.8B | -13% |
| Q1 2025 | $2.5B | -27% |
| Q4 2024 | $3.3B | -22% |
STM's revenue is recovering but still below its 2023 peak: $3.8B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +5.8 points |
| Q2 2026 | 6.3% | +7.2 points |
| Q1 2026 | 3.1% | +4.6 points |
| Q4 2025 | 6.2% | -4.9 points |
| Q3 2025 | 5.1% | -6.6 points |
| Q2 2025 | -0.9% | -13 points |
| Q1 2025 | -1.5% | -17 points |
| Q4 2024 | 11% | -13 points |
STM's operating margin was 11% last quarter, up 5.8 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over STM on cash flow, with more consistent year-over-year improvement.
STM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$121.5M | +$139.5M |
| Q1 2026 | $155.5M | +$182.5M |
| Q4 2025 | -$62.5K | -100% |
| Q3 2025 | $182.4M | +9019% |
| Q2 2025 | -$261M | -2275% |
| Q1 2025 | -$27M | +$108M |
| Q4 2024 | $65M | -83% |
| Q3 2024 | $2M | -100% |
STM's free cash flow has turned positive again: $216M over the past year, against −$221M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over STM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
STM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +3.7M shares |
| 1 year | +1.4% | +12.8M shares |
| 3 years | -1.3% | -12.1M shares |
| 5 years | +1% | +8.9M shares |
| Available history | +2.4% | +21.7M shares |
STM has 932M diluted shares, up 1.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $184M |
| Q3 2025 | — |
| Q2 2025 | $92M |
| Q1 2025 | $92M |
| Q4 2024 | $92M |
| Q3 2024 | $92M |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over STM on leverage, with a lower net debt burden relative to earnings.
STM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.2x | Very low |
STM's net debt is less than a year of its operating earnings (EBITDA).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
STM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.7 | Neutral |
| Stochastic | 22.3 | Neutral |
STM's weekly RSI is 46 (neutral) and its Stochastic is 22 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over STM on valuation relative to its sector.
STM PE vs Technology Sector
| Metric | STM | Sector median | Relative |
|---|---|---|---|
| PE | 83x | 28x | 198% above |
| PE % | 90 | 35 | 55 pts above |
STM is trading at 83x earnings, a 198% premium to the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
STM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.2 | 3.6% below |
| 20 week MA | $52.8 | 12% below |
| 50 week MA | $46.8 | 0.6% below |
| 100 week MA | $36.2 | 28% above |
| 200 week MA | $39.0 | 19% above |
STM has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
STM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $36.9 | +36% |
| 2021 | $36.9 | $48.6 | +32% |
| 2022 | $48.6 | $35.9 | -26% |
| 2023 | $35.9 | $50.1 | +40% |
| 2024 | $50.1 | $25.5 | -49% |
| 2025 | $25.5 | $26.2 | +3% |
| 2026 YTD | $26.2 | $46.5 | +77% |
STM has the edge over NVDA on returns for 2026, with the stronger performance.